Trump ends Medicare drug premium subsidies — millions of seniors face higher costs

The Trump administration plans to end subsidies that have kept Medicare prescription drug premiums lower, potentially raising costs for millions of older Americans starting next year. The change affects Medicare Part D, the programme covering prescription drug costs for seniors. Experts warn the move could push many seniors to switch to Medicare Advantage plans.